Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 20397 / DOSAGE - TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| TIZANIDINE HYDROCHLORIDE(UNII: B53E3NMY5C) (TIZANIDINE - UNII:6AI06C00GW) | TIZANIDINE | 4mg |
Inactive Ingredients
| Ingredient Name | Acorda Therapeutics, Inc. | PD-Rx Pharmaceuticals, Inc. |
|---|---|---|
| ANHYDROUS LACTOSE(3SY5LH9PMK) | ||
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | ||
| GELATIN(2G86QN327L) | ||
| SILICON DIOXIDE(ETJ7Z6XBU4) | ||
| STEARIC ACID(4ELV7Z65AP) | ||
| TITANIUM DIOXIDE(15FIX9V2JP) |
LOOKING FOR A SUPPLIER?
